Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections

Brain Research

Volumn 710, Issue 1-2, 1996, Pages 121-124

  Schröder, Ulrike ^a   Sabel, Bernhard A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Analgesia; Blood brain barrier; Dalargin; Mouse; Nanoparticle; Poly(butylcyanoacrylate)

Indexed keywords

LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; POLYMER; POLYSORBATE 80;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; HOT PLATE TEST; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0343267787     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01375-X     Document Type: Article

References (13)

1. Alyautdin, R., Gothier, D., Petrov, V., Kharkevich, D. and Kreuter, J., Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41 (1995) 44-48.
2. Banks, W.A., Audus, K.L. and Davis, T.P., Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs, Peptides, 13 (1992) 1289-1294.
3. Banks, W.A. and Kastin, A.J., Peptide transport systems for opiates across the blood-brain barrier, Am. J. Physiol. Endocrinol. Metabol., 259 (1990) E1-E10.
4. Bodor, N., Prokai, L., Wu, W.M., Farag, H., Jonalagadda, S., Kawamura, M. and Simpkins, J., A strategy for delivering peptides into the central nervous system by sequential metabolism, Science, 257 (1992) 1698-1700.
5. Borchart, G., Kenneth, L.A., Fenglin, S. and Kreuter, J., Uptake of surfactant-coated poly(methylmethacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers, Int. J. Pharmacol., 110 (1994) 29-35.
6. Friden, Ph.M., Receptor-mediated transport of therapeutics across the blood-brain barrier, Neurosurgery, 35 (1994) 294-298.
7. Kalenikova, E.I., Dmitrieva, O.F., Korobov, N.N., Zhukova, S.V. and Tischenko, V.A., Farmakokinetika dalargina, Vopr. Med. Khim., 34 (1988) 75-83.
8. Kreuter, J., Evaluation of nanoparticles as drug-delivery systems. I. Preparation methods, Pharm. Acta Helv., 58 (1983) 196-209.
9. Kreuter, J., Alyautdin, R.N., Kharkevich, D.A. and Ivanov, A.A., Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles), Brain Res., 674 (1995) 171-174.
10. Oldendorf, W.H. and Szabo, J., Amino acid assignment to one of the three blood-brain barrier amino acid carriers, Am. J. Physiol., 230 (1976) 94-98.
11. Scheld, W.M., Drug delivery to central nervous system: General principles and relevance to therapy for infections of the central nervous system, Rev. Infect. Dis., 11 (1989) S1669-S1690.
12. Tröster, S.D., Müller, U. and Kreuter, J., Modification of the body distribution of poly(methylmethacrylate) nanoparticles in rats by coating with surfactants, Int. J. Pharmacol., 61 (1990) 85-100.
13. Zhou, X. and Huang, L., Targeted delivery of DNA by liposomes and polymers, J. Contr. Release, 19 (1992) 269-274.